01
Racetam grey area
Some nootropic compounds sit in regulatory grey zones. Mainstream agencies do not navigate them.
IND-NOO / Industry hub Nootropics
Nootropic
Marketing
Agency .
Marketing for nootropic brands and cognitive supplement retailers.
Built around the supplement-claim line, the racetam grey area, and the customers who research in detail before they buy.
Get in touch → 01 Approach What we bring → what you get
We bring the asset You get the outcome
01
We bring
Team fluent in racetams, modafinil/analogues, designer compounds (PRL-8-53, Bromantane, Semax, Selank, Noopept), benzo dynamics, and stack design.
You get
Site copy that respects the audience’s research depth and converts on the first read
02
We bring
PBN of 30+ biohacking, nootropic, longevity, and cognitive-enhancement domains.
You get
Compounding domain authority in a YMYL-adjacent category
03
We bring
60+ accounts on nootropic forums, r/Nootropics, and biohacking Discord servers.
You get
Direct community presence in the audience driving most nootropic purchase decisions
04
We bring
Network of biohacking creators across YouTube, Substack, and Reddit.
You get
Influencer reach in the community that drives most category sales
05
We bring
Email and community infrastructure for repeat-purchase optimisation on a high-LTV category.
You get
LTV growth on a category with strong retention dynamics
02 Why other agencies won’t do it 5 reasons mainstream agencies pass
02
Mainstream platforms restrict aggressively
Meta and Google enforce supplement-claim policy unpredictably. Cognitive-enhancement claims trigger reviews.
03
YMYL quality bar
Nootropic content is YMYL-classified. Quality signal requirements are higher than mainstream ecom.
04
It is genuinely hard
You can’t sell what you don’t understand, and people who understand nootropics are rarely working as copywriters. Our team hits both marks: expertise across the spectrum of compounds and excellent on-brand content that does not compare every second compound to NZT.
05
They are not ready
If you treat nootropics like any other category, you will try to outrank Mayo Clinic and Health Canada. That is a waste of budget. We started building the infrastructure a year ago so you can jump in prepared.
03 Why you need this Buyer-intent demand in the vertical
The buyer-intent search demand for nootropics is real, direct, and largely under-served by operators who do not invest in marketing infrastructure. The data below illustrates the categories your customers are already searching for. Ranking, paid placement, and direct-channel presence on these queries are direct revenue.
| Buyer-intent keyword | Monthly search volume |
|---|---|
| best nootropics | 14,800/mo |
| nootropic stack | 8,100/mo |
| buy modafinil | 14,800/mo |
| noopept dosage | 4,400/mo |
04 Our services for nootropics Each link opens a service-specific page
SVC-001
SEO for Nootropics
Local, eCom, parasite, PBN, negative-defense.
SVC-002Nootropics Ads
Paid acquisition across compliant platforms and gray-market networks.
SVC-003Nootropics Reputation Management
Press, suppression, review management, crisis communication.
SVC-004Nootropics Community
Forum, Reddit, Discord, Telegram. Community-driven reach where it matters.
SVC-005Nootropics Sales
Funnel, retention, upsell, conversion rate optimization.
SVC-006Nootropics eCommerce Development
Conversion-tuned brand and store sites. Built for the vertical.
SVC-007Content for Nootropics
Niche-fluent copy and editorial that respects the audience.
SVC-008Nootropics Consulting
Strategy, audits, contingency planning, founder advisory.
05 From nootropics clients Anonymised at client request
Most agencies suggested we soften our positioning. They suggested we sharpen it. Conversion rate doubled.
Their team understood the racetam landscape better than my own chemist. Site copy and product framing got rewritten in a week. Conversion rate went up the next month.
06 Nootropics Marketing FAQ The questions nootropics operators ask first
01 Can you work with racetam-based brands?
Yes. Racetams sit in regulatory grey zones in some jurisdictions, and we work with brands operating across that spectrum. The audit calibrates the marketing posture to your specific compounds and the markets you ship to.
02 What about modafinil and prescription analogues?
Yes. We work with modafinil retailers and adjacent prescription-analogue brands operating in jurisdictions where it is workable for both sides. Acquisition runs through forum, community, and biohacker-creator channels rather than mainstream paid.
03 How is nootropic content different from supplement content?
The audience is more research-driven and reads more deeply. Content has to respect that depth or lose conversions on the very buyers most likely to retain.
04 Do you work with new nootropic brands?
Yes. Early-stage nootropic brands need the same foundation work as established ones — site, deliverability, payment infrastructure, content baseline. The audit identifies what to build first; the retainer builds it.
05 Can you handle benzo-derivative compounds?
In jurisdictions where the specific compound is legal. Etizolam, flubromazepam, diclazepam, and the rest sit in different positions across markets. We calibrate engagement to your stack and shipping geography.
06 Can you reach nootropic buyers without mainstream platforms?
Yes. Most nootropic acquisition runs through r/Nootropics, biohacking Discord servers, longevity creator content, and forum-driven SEO. Mainstream paid channels are a supplement, not the foundation.
07 Start the conversation Reply within 24h. Mutual NDA on request.
Tell us what you’re working on.
Most engagements start with a three-week audit. The form below tells us enough to scope the call. Or write directly: contacts@despitemarketing.com. Your brief goes straight to a partner, not a triage queue.